Thermofisher Scientific Inc., Illumina, Inc. and Agilent are dominating the Global microRNA Reverse Transcription Market in 2022

Global MicroRNA Reverse Transcription Market is expected to grow with the CAGR of 16.4% in the forecast period of 2022 to 2029. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-microrna-reverse-transcription-market

Global microRNA reverse transcription market is a highly consolidated market. The market has witnessed increased strategic developments owing to favorable market scenario.

The major players dealing in the global microRNA reverse transcription market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.

Thermo Fisher Scientific, Inc. is dominating player in the global microRNA reverse transcription Market. The other key players existing in the market includes are Horizon Discovery Ltd., QIAGEN, Quantabio, BioGenex, NanoString, OriGene Technologies, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc, HTG Molecular Diagnostics, Inc., SeqMatic LLC., System Biosciences, LLC., GeneCopoeia, Inc., Abcam plc., Takara Bio Inc., New England Biolabs, MiRXES Pte Ltd., Miltenyi Biotec, Applied Biological Materials Inc., Norgen Biotek Corp., Nanjing Vazyme Biotech Co., Ltd., Mereck KGaA, Darmstandt, Germany, Illumina, Inc., GenoSensor Corporation among others.          

microRNA Reverse Transcription MarketThermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. headquartered in Massachusetts, U.S. The company is focusing on are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies. The company operates its business through several business segments including Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products among which Life Sciences Solutions is market focused segment. The company offers the products through several product categories including Life Sciences, Industrial & Applied Science, Clinical & Diagnostics, Lab Solutions, Digital Solutions among which Life Sciences is the market focused category. The company is taking strategic initiatives to increase its portfolio.

For instance,

  • In March 2020, Thermo Fisher Scientific Inc. acquired QIAGEN N.V. which is one of the leading provider of molecular diagnostics and sample preparation technologies. The company’s sample preparation technologies are used for isolation and extraction of RNA, DNA and proteins from a wide range of biological samples. This acquisition enhanced the company’s existing product portfolio and allowed it to expand its footprint in global microRNA reverse transcription market.

The company has various subsidiaries including Thermo Fisher Scientific Operating Company LLC (Delaware), Fisher Clinical Services (Suzhou) Co., Ltd. (China), Phadia GmbH (Germany), Thermo Fisher Scientific Africa Proprietary Ltd (South Africa), Thermo Fisher Scientific India Pvt Ltd (India), Thermo Ramsey S.A. (Spain) among others. The company has global presence in Asia Pacific, Europe, Americas and Middle East & Africa.

Illumina, Inc.

Illumina, Inc. was founded in 1998 and is headquartered in California, U.S. The company is focusing on providing innovative sequencing and array technologies are fuelling ground breaking advancements in life science research, translational and consumer genomics, and molecular diagnostics and also company is fuelling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. The company has two business segments including Core Illumina and GRAIL, among which Core Illumina is the market focused segment. The company has several product categories including Instruments, Kits & Reagents, Selection Tools, Software & Analysis, among which Kits & Reagents, Instruments is the market focused category. The company is taking strategic initiatives including business expansion, partnership among others to increase its product portfolio.

For instance,

  • In September 2021, Illumina, Inc. announced the creation of Illumina Colombia S.A.S. and Illumina México Productos de Biotecnología with an aim to expand genomics in Latin America and to boost up the level of support for partners and customers. This business expansion enhanced the company’s existing revenue.

The company has global presence in Asia Pacific, Americas, Middle East & Africa and Europe. The company has two subsidiaries including GRAIL Biotechnology Company (U.K.) and Illumina GmbH (Germany).

Agilent Technologies, Inc.

Agilent Technologies, Inc. was founded in 1999 and is headquartered in California, U.S. The company is focusing on life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. The company operates its business through two business segments including life sciences and applied markets business, diagnostics and genomics among which life sciences and applied markets business is the market focused category. The company has several product categories including Analytical Instruments & Supplies, Life Science, Clinical & Diagnostic Testing, Lab Management & Consulting, Dissolution Testing, Lab Software, Lab Supplies, Vacuum & Leak Detection among which Life Science is the market focused category. The company is increasing its geographic presence such as:

  • In February 2021, Okuvision announced its expansion into Great Britain hence continuously working to make the OkuStim therapy more accessible.

The company has various subsidiaries companies including Agilent Technologies Singapore Pte. Ltd. (Singapore), Agilent Technologies Deutschland Holding GmbH (Germany), Agilent Technologies Sanigi B.V. (Netherlands), Agilent Technologies World Trade, Inc. (Delaware), Agilent LED International (California) among others. The company has global presence in Asia Pacific, Europe, Americas and Middle East & Africa.